Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming video

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like diabetes, cardiovascular

Obesity is a complex, multifactorial condition defined by excessive adiposity and associated health risks.1 The rising prevalence of obesity contributes to the increasing global burden

Popular weight loss drugs like GLP-1 injections are helping millions of people lose pounds. But a new study shows that stopping these medications can cause

It’s not a cure.

Data from Circana and Technomic reveal shifting dining habits among weight loss drug users

A new study finds that people who quit weight-loss medications, including GLP-1 drugs, regain weight four times faster than people who stop dieting or exercising

Mike Stobe/Getty Images President Donald Trump admitted he “probably” should be on the “fat drug.” Trump, 79, got quizzed about his use of GLP-1 drugs

The Daily Beast reports: Trump admitted he “probably” should be on the “fat drug.” Trump, 79, got quizzed about his use of GLP-1 drugs such

House Republicans have asked the leaders of some of the nation’s largest health insurers to testify before Congress at the end of January as scrutiny

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like diabetes, cardiovascular

Medifast, Inc. MED is moving beyond its traditional identity as a weight-loss company to establish itself as a leader in the expanding metabolic health market.

People on average regain weight at a rate of 0.4 kg/month after they stopped taking their weight loss medications, a review of 63 trials covering

Oat Lime Cinnamon Drink, The Oatzempic Trend Explained, What It Really Does In Your Body You have probably seen the viral Oatzempic drink all over

The Offer No direct link to offer, check your emails/app Smoothie King is offering a free 12 oz Activator Recovery GLP-1 Almond Berry Smoothie Our

Kallyope Inc. has outlined plans to initiate phase I studies this year with K-554, a non-incretin peptide candidate offering a new mechanism of action in

CES 2026 had no shortage of AI products, but a quieter pattern stood out across booths that had little else in common. Some of the

Eli Lilly said Thursday that adding its weight loss drug Zepbound on top of its immunology therapy Taltz helped obese patients with an autoimmune condition

New Phase 3b data from Eli Lilly suggest that its blockbuster weight loss drug helped boost the efficacy of an autoimmune treatment in select patients

Eli Lilly LLY has pursued a series of acquisitions since early 2025 to strengthen its pipeline and support long-term growth amid intensifying competition in the obesity

Former GLP-1 users regain lost weight after about 18 months, study says  The Washington Post People Who Stop Taking Weight-Loss Medications Regain Weight Within 2 Years,

GoodRx has named 20 medications and vaccines as the most influential FDA approvals of 2025, spotlighting first-in-class drugs, new indications, and therapies with the potential

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a lower risk for acute asthma exacerbations in adolescents with overweight or obesity, according to

DUBLIN–(BUSINESS WIRE)–The “GLP-1 Market: Industry Trends and Global Forecasts, Till 2035” report has been added to ResearchAndMarkets.com’s offering. The global GLP-1 market is estimated to

The use of glucagon-like peptide-1 (GLP-1) receptor agonist drugs for weight loss is increasing rapidly, with an estimated one in 50 adults in the UK

New data published in the British Medical Journal suggests overweight people shed large amounts when they take weight-loss drugs, but once they quit they regain

Novo Nordisk is trying to get back on track in the U.S., but it just lost an important worker in Washington. An internal memo said

Those quitting Ozempic, Wegovy and other drugs regained weight four times faster than those using just diet and exercise, still key components in weight maintenance.

The U.S. poured $4.9 trillion into health care in 2023, equal to roughly 17.6% of GDP, federal data show. What jumps out from that number

The poll of 2,000 US adults found nearly a quarter currently use GLP-1s or have used them within the past five years.

The opening days of 2026 have seen a clutch of UK retailers roll out products with an eye on the rising number of people using

Cal-Maine Foods, Inc. (NASDAQ:CALM) Q2 2026 Earnings Call Transcript January 7, 2026 Cal-Maine Foods, Inc. beats earnings expectations. Reported EPS is $2.13, expectations were $1.75.

Albertsons Companies, Inc. (NYSE:ACI) Q3 2026 Earnings Call Transcript January 7, 2026 Albertsons Companies, Inc. beats earnings expectations. Reported EPS is $0.72, expectations were $0.67.

Stopping popular weight-loss shots brings a risk of rapid weight gain, according to new research. A review of 37 clinical trials and observational studies involving

Exclusive: Haul of illicit products led by medicines regulator was described as world’s largest of its kind, but no arrests have yet been made Wedged

CES is famous for ushering in big TVs, faster chips and serious upgrades to the tech we already use every day. It’s also where companies

CES 2026’s second day was all about hands on time with new tech. From Lego’s most ambitious play experiment yet to assistive mobility tech, smart

Thumb Score: 0 Grab your FREE 12 oz Activator® Recovery GLP-1 Almond Berry smoothie, today only. In app or online

Post Content

Today only, get a free 12-oz. smoothie by simply opening up the app and going to the rewards section. (You’ll need to be a rewards